Abstract
This editorial discusses the ways in which evidence-based practice should be developed and evaluated, from first hypotheses to gold standard ‘blind’ randomised control trials but also acknowledges that parents, educators and therapists usually have to make decisions on how to best help children with Down syndrome in the absence of this evidence. Guidance is offered on the ways in which new therapies can be evaluated, arguing strongly for objective evaluations and the avoidance of unproven and scientifically implausible approaches.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
